Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nomad Bioscience is a plant biotechnology company that develops transient expression systems for the large-scale production of recombinant proteins. The company's proprietary magnICON platform enables the rapid and high-yield manufacture of biologics, including antibacterial proteins (colicins and salmocins), antiviral proteins, and therapeutic antibodies. Nomad Bioscience primarily focuses on food safety, addressing contamination from pathogens like E. coli and Salmonella, as well as human health applications such as Clostridioides difficile treatments. By utilizing molecular farming, the company aims to provide cost-effective and scalable alternatives to traditional fermentation-based manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nomad Bioscience.